Innovation Pharmaceuticals Inc (IPIX)

[taas]

Pressure on Gilead to do a deal. Down 9% today. Maybe they should talk to Cellceutix? From Dow Jones News:

"Gilead Sciences (GILD) off more than 9% after it reported last night that sales of two key hepatitis C drugs plunged in 4Q and would face pressures this year, too. Wall Street is encouraging the company to do a deal to fuel growth, and executives indicate they are looking, though they emphasize they want to make sure any acquisition would be a good fit. One problem: there just aren't a lot of decent-sized targets left, after a string of take-outs by other big companies, such as Pfizer's (PFE) acquisition of Medivation."